Active	Status	Sponsor type	Region	Phase	Filter
1 Active 73 Inactive 74 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   - « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Juvenile Myelomonocytic Leukemia
NCT00960050: Methemoglobinemia in Patients With Childhood Hematologic Cancer or Aplastic Anemia Treated With Dapsone	Active, not recruiting	1	173	US	polymorphism analysis, laboratory biomarker analysis, medical chart review, assessment of therapy complications	Vanderbilt-Ingram Cancer Center, National Cancer Institute (NCI)	Leukemia, Lymphoma, Methemoglobinemia, Nonmalignant Neoplasm	05/15

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Juvenile Myelomonocytic Leukemia
NCT00960050: Methemoglobinemia in Patients With Childhood Hematologic Cancer or Aplastic Anemia Treated With Dapsone	Active, not recruiting	1	173	US	polymorphism analysis, laboratory biomarker analysis, medical chart review, assessment of therapy complications	Vanderbilt-Ingram Cancer Center, National Cancer Institute (NCI)	Leukemia, Lymphoma, Methemoglobinemia, Nonmalignant Neoplasm	05/15